Bone Drug Suppresses Wandering Tumor Cells in Breast Cancer Patients, Washington University School of Medicine Study

Newswise — The bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery, suggests research at Washington University School of Medicine in St. Louis.

Back to news